Discover how agentic AI and expert governance can reduce HTA evidence burden, improve market access readiness, and strengthen payer confidence.
Master HTA Decision Readiness to navigate complex assessments and present compelling value arguments for market access.
Explore insights from our dinner event at Reuters Pharma Barcelona, where industry leaders shared valuable perspectives on pressing topics.
At the upcoming ISPOR 2026, Evalueserve will contribute to the ongoing dialogue shaping the future of healthcare decision-making.
Explore takeaways from our recent executive roundtable on AI Transformation in Life Sciences and Healthcare.
Explore how AI agents revolutionize systematic literature reviews, enhancing efficiency and strategic agility in evidence generation for pharmaceutical companies.
Pharma Portfolio Strategy teams navigate high-stakes partnerships, evaluating clinical pipelines, market dynamics, and competitive landscapes—decisions that can shape a company’s future—while reducing the 550+ hours typically spent per opportunity.
At an exclusive dinner in Copenhagen, Nordic biotech and pharma leaders explored how AI, innovation, and collaboration are shaping the future of life sciences and positioning the region for global impact.
Unveil groundbreaking advancements in life sciences as AI, genomics, and digital health reshape patient care and streamline clinical processes.
Ahead of ASCO 2025, Evalueserve brought together top oncology leaders for a private dinner focused on AI, precision medicine, and the evolving oncology market—fostering open dialogue and strategic insight-sharing.
To compete in a fast-moving landscape, a leading company in the benefits industry partnered with Evalueserve to centralize and scale its competitive intelligence.
Evalueserve helped a global biopharma leader unify and accelerate medical conference intelligence across six disease areas—delivering faster insights, stronger collaboration, and measurable cost reductions.
Evalueserve sponsors Reuters Pharma USA 2025—meet us to explore AI-powered solutions driving pharma innovation and success.
With AI, big data, and regulatory advancements at the forefront, the sector is poised to deliver innovations that address healthcare challenges while ensuring equitable access across the region’s diverse markets.
Join us for two days of insightful discussions, networking opportunities, and the latest innovations in pharma competitive intelligence.
Strengthen your brand’s market position with data-driven insights and strategic recommendations to enhance Order-to-Cash processes and customer satisfaction.
Join Dr. Kelkar for an interactive and compelling look into how Bayer is planning on redefining the integration of AI in pharmaceutical intelligence, ensuring strategic and timely decision-making.
Explore FDA’s requirements on CAR-T Therapy, as it mandates black box warnings for six approved therapies, prioritizing patient safety in the evolving market landscape.
Evalueserve completed two primary market research projects for a leading multinational medical device company. The medical device company now has a complete view of anticipated changes in the market and can plan their strategy accordingly.
A glimpse of orthopedic industry and recent updates. Top orthopedic players boosting the ortho market with new innovations and technologies. Key highlights showcasing the advancement and trends in the market.
The competitive intelligence team at a prominent pharma company faced resource and personnel constraints that caused them to miss key competitive updates across their portfolio. They brought Evalueserve on to assemble a specialized team and implement their Insightsfirst platform.
Summary A Fortune 500 biopharma company wanted to improve its competitive intelligence (CI) efforts to drive long-term growth. They had challenges
Unlock social influence using Digital Opinion Leaders (DOLs). Discover their role in shaping opinions through social media, blogs, and podcasts. Learn how Evalueserve identifies impactful DOLs for your success.
Explore how Evalueserve supported one of the leading orthopedic medical device manufacturers by demonstrating its competitive intelligence expertise and using its technical knowledge in the MedTech space and proprietary AI tools.
Evalueserve IP and R&D Drive Innovation with Strategic IP and R&D Solutions Visit Website Introduction Key Opinion Leaders (KOLs) are crucial
A medical devices company engaged Evalueserve to gather intelligence on diabetes care-related market trends and competitor strategies to enhance its market position. Through in-depth analysis and research, they uncovered market gaps, refined their strategies, and executed timely action for better business outcomes.
A leading hearing aids company was seeking to competitively position its products in the US market, based on its competitors’ product features, price to franchise and final price to end-users, bundling options in terms of end-user prices and the price mark-ups.
Know how Evalueserve’s proprietary AI-driven platform provided actionable competitive intelligence and enabled a leading B2B scientific and laboratory equipment supplier to scale up its CI program and go-to-market strategies.
In today’s post-pandemic era, industries across the board are witnessing remarkable transformations, and the pharmaceutical industry is no exception. This critical pillar of the healthcare sector is undergoing a profound transformation fueled by the power of digitalization.
Explore the rapidly evolving world of clear aligners and their integration into digital dental workflows. Learn about top dental companies, workflow compatibility, and the benefits of seamless integration for dentists and patients.
A MedTech company partnered with Evalueserve to thoroughly examine its competitors, gaining valuable insights to enhance its market position. Through in-depth analysis and research, they proactively anticipated market shifts, refined strategies, and made informed decisions to strengthen their position.
Discover the highlights of ASGCT Annual Meeting 2023, featuring breakthroughs in biotechnology, novel approaches, and innovative technologies in the CGT space. Stay updated on the latest advancements and industry trends.
POV on Clear Aligners: Current & Future Trends Get My Publication Overview Traditionally, orthodontists used to treat malocclusion cases among kids,
Explore how AI-driven data insights revolutionized KOL engagement in the pharmaceutical industry, enabling unbiased collaboration, informed decision-making, and enhanced patient outcomes.
Discover the key factors in choosing a hearing aid, from severity of hearing loss to warranty and trial periods. Explore the latest technological advancements and growing demand for OTC products.
With the consistent success of cell and gene therapies (CGTs), bioprocessing and the manufacturing facilities have taken centre-stage to meet global demands.
Digital technology, such as AI, big data analytics, wearables, and robotics, has revolutionized healthcare in the past decade with surgical robotics, improving accessibility, efficiency, and equity.
Healthcare is rapidly transforming with digital health, offering benefits like improved patient outcomes, greater efficiency, and cost reduction. However, realising these advantages requires close collaboration between healthcare providers, policymakers, and technology companies. By working together, a cohesive ecosystem can be created that uses technology to deliver patient-centric care.
In the rapidly evolving field of ophthalmic surgery, staying at the forefront of technological advancements and understanding the competitive landscape is crucial for success. With increasing demands for better patient outcomes and cost-effective solutions, market players are constantly striving to innovate and outperform their competitors. Our medtech team has expertly curated a comprehensive analysis, delving into the strategic perspectives of key competitors, emerging trends, and future outlook across four essential pillars shaping the ophthalmology landscape.
Each year, the incidence of transplants is increasing. Consequently, population of patients with Graft-versus-Host Disease (GvHD) is on the rise. This is especially true for chronic GvHD for which the incidence has been recorded as high as 80%. The frontline treatment is dominated by corticosteroids and other immunosuppressants. However, the refractory nature of the disease requires patients to move on to later lines of treatment, which currently are limited.
Almost 80-85% of the post-menopausal women population in the world suffer from vasomotor symptoms (VMS) such as hot flashes, night sweats and other associated symptoms. However, due to the stigma and misinformation associated with women’s health and especially menopause, it still remains an area that is understudied in research, often misunderstood by healthcare providers and patients, and unaddressed by most healthcare policies.
As a central driving force for precision medicine worldwide, the Personalized Medicine Coalition (PMC) noted that more than 220 FDA-approved therapies with a biomarker mentioned in the label as ‘essential’ or ‘recommended for prescribing’ were available in the US market between 2015 and 2021. Further fuelling the movement of value-based care, a drug-diagnostic co-development model has been significantly prevalent, leading to a consistently growing usage of companion diagnostics assays – to target patients expected to benefit most from targeted therapy. As of 2022, 40+ commercialized CDx assays were listed exhaustively in the FDA’s List of Cleared or Approved Companion Diagnostic Devices.
Thermo Fisher Scientific had issues with its existing competitive intelligence program, so Evalueserve implemented our Insightsfirst platform for them.
A leading pharmaceutical company approached us to support its yearly forecasting cycle, as well as the development of new patient-based models in different therapy areas.
A global pharmaceutical conglomerate wanted to evaluate a portable multi-use device’s potential adoption, coverage, and price acceptance.
Conference intelligence is a crucial piece of competitive intelligence, particularly in the pharma sector. And employing AV analytics and AI adds new layers of value to traditional conference intelligence offerings.
Acute Myeloid Leukemia (AML) is a uniquely challenging disease in which 50-80% patients eventually relapse following induction and/or post-remission therapies and with 5-year survival rate of merely 30%. Drug development in AML has been challenging in the past, with multiple failures and modest commercial success.
The Evalueserve medtech team summarizes highlights from key medical devices and diagnostic players presented and discussed at JP Morgan Healthcare Conference 2023.
An F500 Pharmaceutical company discovered that Searchstream provided a straightforward and efficient way to request their patent search, which was essential to their workstream given the rapidly advancing technology and the demand for more frequent searches.
Evalueserve brings to you a brief snapshot of epilepsy showcasing current market, future trends and potential recommendations in the space, read our brief take on Epilepsy Perspective and Trends.
ASH 2022 (Dec 10-13) is approaching and destined to re-energize and re-catalyse the global hematology community. Here are some picks of key players and interesting abstracts in CAR-T and T-Cell Engager space.
A pharmaceutical company wanted to better monitor its sector. Because the industry is private in nature, the best place to gain insights is at industry events, but did not have the necessary resources to attend every industry conference and the corresponding sessions.
The Cell and Gene Therapy (CGT) Area has gained traction in recent years. A majority of big pharma has CGT assets in their pipeline. While it has a strong pipeline, the area witnessed a continued flow of investment. In our latest industry report on Cell and Gene Therapy Sector Performance and Outlook, we discuss how and why we believe that the CGT area has a lot to offer and except to see continued growth.
Evalueserve implemented a continuous monitoring program for a global healthcare company that wanted to monitor its competitors, the latest technologies, and IP developments in the healthcare domain.
ESMO 2022 (09-13 September) has concluded. Evalueserve presents succinct reflection of key abstracts that managed to create significant stir across five broad themes of ADCs, Precision Oncology, Early Assets, Practice informing readouts and Out of the box findings. The report uncovers clinical data spotlight accompanied with latest industry perceptions and Twitter intelligence.
As ESMO 2022 (09-13 September) is quickly approaching, Evalueserve presents glimpse of some of the abstracts making hot conversations on social media, industry forums and blogs. Study highlights supplemented with asset deep-dive and KOL/ analyst’s views on upcoming data presentations.
HFSA 2022, one of the largest and most sought after Cardiovascular conferences that brings world’s leading cardiovascular experts in heart failure together on a common platform, is being held from Sep 30th to Oct 3rd 2022, in Washington this year!
A MedTech pioneer, being a giant in the medical devices industry, needed to monitor a pool of therapeutic areas. They needed a singular centralized solution to get all insights, which they could then distribute internally to the respective stakeholders.
After successfully serving a leading global medical device company in different segments to stay abreast of their close competitors through extensive competitive (CI) monitoring, Evalueserve was internally recommended to their orthopedic department to conduct customized competitive intelligence programs in the orthopedic space on Insightsfirst.
Digital healthcare gained great prominence following the outbreak of COVID-19, as patients wanted to feel more empowered than ever before. Many venture funds stepped up to fund advanced digital health technology companies that were focused on AI-based data-driven connected technologies.
The post-conference report curated by Evalueserve mirrors the most impactful findings from lung cancer, breast cancer and acute myeloid leukemia in 2022.
With more novel drugs being launched and approved, pharmaceutical new product launch strategies need to evolve.
The COVID-19 pandemic has made the healthcare ecosystem and engagement for launch effectiveness more complex owing to the evolving needs of pharma stakeholders.
The ICER has backed bluebird bio’s revolutionary Zynteglo therapy for beta thalassaemia as cost-effective in their draft report. Will FDA’s additional back-to-back endorsement of Zynteglo and eli-cel pave the way for bluebird’s recovery, despite multiple misfires and dwindling finances?
AI can be found throughout clinics and hospitals working alongside doctors, nurses, and specialists. Automated systems help flag risk factors, identify likely conditions, and assist medical professionals with other vital forms of diagnoses and treatment. Our resident brand journalist Leah Moore spoke to our in-house AI expert Cathy Feng to learn more about the state of AI in the medical field.
ASCO 2022, the premier global event in oncology is around the corner. The conference provides an opportunity to explore the latest advancements in oncology. Our pre-conference preview provides strategic presentations from key players (AstraZeneca, Bristol-Myers Squibb, Merck & Co., Novartis, and Roche), top 6 discussed abstracts by oncologists, and spotlight sessions from trending themes (breast cancer, lung cancer, hematology-oncology and immunotherapy).
The start of 2022 has been in stark contrast to the economic buoyancy witnessed last year. Even though it has been almost two years since the outbreak of COVID-19, the pandemic is still proving to a challenge for governments across the globe.
It has been almost two years since the outbreak of COVID-19, but the pandemic still rages on. Vaccine rollout and policy support have continued to witness divergence across regions. The consistent and equitable implementation of tools to control the pandemic continues to be a challenge for governments across the globe.
Global Healthcare Market – 2021 It’s been over 16 months since the start of the pandemic, and we are still fighting
Do you have optimal processes for refreshing customer documentation such as KYC reports and performing handovers to relationship managers? We understand the challenges involved. Let us help you acquire information with minimum hassle to customers, deal with foreign language documentation and more.
Do you have optimal processes for refreshing customer documentation such as KYC reports and performing handovers to relationship managers? We understand the challenges involved. Let us help you acquire information with minimum hassle to customers, deal with foreign language documentation and more.
Do you have optimal processes for refreshing customer documentation such as KYC reports and performing handovers to relationship managers? We understand the challenges involved. Let us help you acquire information with minimum hassle to customers, deal with foreign language documentation and more.
Do you have optimal processes for refreshing customer documentation such as KYC reports and performing handovers to relationship managers? We understand the challenges involved. Let us help you acquire information with minimum hassle to customers, deal with foreign language documentation and more.
Do you have optimal processes for refreshing customer documentation such as KYC reports and performing handovers to relationship managers? We understand the challenges involved. Let us help you acquire information with minimum hassle to customers, deal with foreign language documentation and more.
Do you have optimal processes for refreshing customer documentation such as KYC reports and performing handovers to relationship managers? We understand the challenges involved. Let us help you acquire information with minimum hassle to customers, deal with foreign language documentation and more.
Do you have optimal processes for refreshing customer documentation such as KYC reports and performing handovers to relationship managers? We understand the challenges involved. Let us help you acquire information with minimum hassle to customers, deal with foreign language documentation and more.
Do you have optimal processes for refreshing customer documentation such as KYC reports and performing handovers to relationship managers? We understand the challenges involved. Let us help you acquire information with minimum hassle to customers, deal with foreign language documentation and more.
Do you have optimal processes for refreshing customer documentation such as KYC reports and performing handovers to relationship managers? We understand the challenges involved. Let us help you acquire information with minimum hassle to customers, deal with foreign language documentation and more.
As the fight against COVID-19 continues, economic recovery across economies has been diverging due to differences in the pace of vaccine rollout and policy support. Mass vaccination drives by advanced economies are driving positive market sentiments.
An international implementing agency is providing technical support to the government of India’s Ministry of Health and Family Welfare (MoHFW) country-wide Rotavirus Vaccination Immunization (RVVI) program.
Q&A with Sid Shivam, Associate VP for Life Sciences and Healthcare.
The COVID-19 pandemic has pushed the world in an economic recession that far worse than the financial crisis in 2008–09. Although many economies have been able to sail through the economic uncertainties, the fatigue induced by the pandemic is creating a new set of problems for governments across the globe.
The shock of the COVID-19 pandemic, and the lockdown measures adopted to contain it, have had a debilitating effect on the global economy. According to the World Bank, the global economy will likely contract by 5.2% in 2020.
The question we must address now is: “How do we interpret claim language?”
Do you have optimal processes for refreshing customer documentation such as KYC reports and performing handovers to relationship managers? We understand the challenges involved. Let us help you acquire information with minimum hassle to customers, deal with foreign language documentation and more.
Globally, the pharmaceutical industry may experience logistics and demand disruptions, but less compared to other sectors. North America and EMEA plan to invest in API facilities to reduce reliance on APAC.
Innovative R&D depends on combined technological, regulatory and IP insights, but how best to find relevant answers? We’ll help you navigate the vast amount of available scientific literature and patents so that you remain innovative, competitive and compliant.
The increased demand on healthcare services will be compounded by the apparent increased risk of infection among healthcare workers.
No one could foresee the impact that the Covid-19 outbreak would have on the different processes we take for granted.
According to the International Monetary Fund, the recession triggered by the pandemic will likely be “way worse” than the 2008–09 global financial crisis.
The Covid-19 pandemic has exposed glaring fault lines in the medical care infrastructure, and in emergency health response systems around the globe.
These blog posts explained the key parameters that searchers need to consider to ensure an effective FTO search.
It’s time now to shatter the long-held myth about dearth of MedTech data and use the power of predictive and prescriptive analytics to gain competitive advantage.
Are you part of the global pharma conversation? Do you have the systems in place to join it? More and more pharmaceutical and healthcare companies are finding the need to actively engage with patients, physicians and key opinion leaders.
Maintaining the headcount and in-house expertise to deal with the full range of IP administration tasks is costly. Our highly trained paralegals and specialists in patent drafting and prosecution are prepared to cover your needs. We can also support you with the business-critical transition from transactional to strategic IP management.
Using dedicated tools and models, our experts will help you gain deeper insights about your competitors, prospects and target industries.
Aware of the potential of social media as a source of marketing, strategy, and adverse event information, a major pharmaceutical company wanted to invest in AOL.